Resources

The UK pavilion at SynBioBeta 2025 will unite leading UK engineering biology companies and ecosystem partners to highlight the UK’s world-class strengths in engineering biology.

It’s Spring Statement week and we have a webinar on what it means for the sector this Friday; also in this blog - why VPAG needs sorting and a new Series C raise for a BIA member, Brainomix.

A big raise as next generation biotech leaders gather, NHS England is abolished, and global trade disputes touch on our industry.

This week, BIA was invited by the Foreign Secretary to represent UK life sciences in Japan. In Parliament, we're championing a robust industrial strategy. Our new report provides the data and real life experience on womens’ leadership in our sector, while a former Board BIA member joins Duran Duran (sort of).

The UKHSA Conference 2025, delivered in partnership with the FPH, will explore the full breadth of UKHSA’s work; from science-driven research to effective policy implementation.

In this week’s blog, HM Treasury considers ISA changes to enable tax support for growth, a new engineering biology regulatory group gives the UK a strategic edge and a key MHRA webinar on ILAP is upcoming.

GitLife Biotech and Colorifix have partnered to enhance traceability and scalability in eco-friendly textile dyeing. The project is supported by Innovate UK.

In the fast-paced world of antibody research, time and efficiency are critical. To meet the growing demand for rapid, high-quality solutions, Biointron has launched a series of innovative small-scale antibody production packages under the RushMab™ brand.

Biointron and Cyagen have joined forces to create a breakthrough platform for discovering fully human antibodies.

RSSL has today announced that it has secured funding from Innovate UK, the UK’s national innovation agency, to establish the country’s first Novel Foods Expert Network for Regulatory Challenges (NFX UK).

The BIA is driving progress across life sciences, from shaping policy in engineering biology and advocating for balanced perspectives in the Covid Inquiry to exhibiting UK innovation at JP Morgan Healthcare Week. 

In this blog, Maddie Cass, Senior Policy and Public Affairs Executive at the BIA, shares our perspective on the recent EngBio public trust survey findings conducted by the DSIT.

UK dealmakers are at the heart of JPM, the Government rolls out AI plan and new MHRA Chair sets priorities.

In this blog Izzy Webb, Deputy Director for technology, strategy and security in the Department for Science, Innovation and Technology (DSIT), discusses the UK Government's survey on engineering biology, outlining its limited public awareness but sharing optimism about its potential to address societal challenges.

Excelra has partnered with Orogen Therapeutics, an innovative DNA-Encoded Library (DEL) and AI-driven biotechnology company currently developing a portfolio of best-in-class small molecule treatments.